Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China

Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) during treatment. The different prevalence and distribution patterns of G6PDd in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Wen, Liu, Ning, Li, Yuchun, Gao, Ai, Yuan, Mengyi, Ma, Rui, Jiang, Na, Sun, Dingwei, Wang, Guangze, Feng, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634581/
https://www.ncbi.nlm.nih.gov/pubmed/36339224
http://dx.doi.org/10.3389/fpubh.2022.1010172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634581/
https://www.ncbi.nlm.nih.gov/pubmed/36339224
http://dx.doi.org/10.3389/fpubh.2022.1010172

Ejemplares similares